PATRICIA ARNOLD: Open Payments
NPI 1811596018 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 23 payments from 10 companies in 2025. Trend: 2023 $205 · 2024 $832 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $116 |
| Biogen, Inc. | 3 | $86 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $74 |
| MILLICENT US INC | 3 | $55 |
| Dexcom, Inc. | 1 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Veozah, ZURZUVAE, FEMRING, Dexcom G6 Transmitter, MYFEMBREE, ZEPBOUND, FEMLYV, MONOFERRIC.
Industry payments across KS — which companies pay providers there.
